Essentials of Model-informed Drug Development in Oncology Blog Post
Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs. Read the blog to learn more…
Non-Animal Navigator™: Expert strategy and AI-enabled biosimulation to reduce, refine, or replace animal studies Blog Post
Download PDF Learn more about Non-Animal Navigator™ Certara’s Non-Animal Navigator™ solution helps companies adapt by selecting and optimizing the best-fit NAM strategies. View Non-Animal Navigator™Contact us You May Also Like...
Combining mechanistic modeling with machine learning to predict clinical scores in inflammatory bowel disease (IBD) Blog Post
June 26, 2025 – 10am ET
Certara to Participate in Upcoming Investor Conferences Blog Post
RADNOR, PA — April 29, 2025 -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:...
Outsourcing in Clinical Trials East Coast 2025 Blog Post
May 20 -21, 2025 – King of Prussia, PA – Booth 50
White Paper Download – Clinical Trial Data Sharing Under EMA Policy 0070 Page
White paper download: Clinical Trial Data Sharing Under EMA Policy 0070 Thank you for downloading! Your download, Clinical Trial Data Sharing Under EMA Policy 0070, is now available below. This white...
Clinical Trial Data Sharing Under EMA Policy 0070 Page
WHITE PAPERClinical Trial Data Sharing Under EMA Policy 0070 The landscape for clinical trial data sharing is evolving rapidly. European Medicines Agency’s (EMA) Policy 0070 requires sponsors to publicly disclose...
RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions Blog Post
May 28, 2025 – 11am ET
Applications of Quantitative Systems Pharmacology Modeling for Vaccine Development Blog Post
Vaccines play a crucial role in preventing diseases and thereby saving countless lives. To prevent the spread of diseases, it is important that vaccines are broadly available in all parts... 